X0609 4 2026-05-15 0001611647 Freshpet, Inc. FRPT 0001680803 Cyr William B. false C/O FRESHPET, INC. 1450 US-206 BEDMINSTER NJ 07921 true true Chief Executive Officer true Common Stock 2026-05-15 4 M 0 62369 10.23 A 208139 D Common Stock 2026-05-15 4 S 0 6104 48.44 D 202035 D Common Stock 2026-05-15 4 S 0 36289 49.46 D 165746 D Common Stock 2026-05-15 4 S 0 300 49.85 D 165446 D Common Stock 2026-05-18 4 M 0 62369 10.23 A 227815 D Common Stock 2026-05-18 4 S 0 32344 48.46 D 195471 D Common Stock 2026-05-18 4 S 0 1526 49.09 D 193945 D Common Stock 2026-05-18 4 S 0 7513 50.36 D 186432 D Common Stock 2026-05-18 4 S 0 1309 51.32 D 185123 D Common Stock 2026-05-15 4 M 0 4620 10.23 A 15545 I By Spouse Common Stock 2026-05-15 4 S 0 959 49.09 D 14586 I By Spouse Common Stock 2026-05-18 4 M 0 4620 10.23 A 19206 I By Spouse Common Stock 2026-05-18 4 S 0 959 50.04 D 18247 I By Spouse Common Stock 2026-05-15 4 M 0 9030 10.23 A 41044 I By Irrevocable Spousal Trust for Linda W. Cyr Common Stock 2026-05-15 4 S 0 1874 49.09 D 39170 I By Irrevocable Spousal Trust for Linda W. Cyr Common Stock 2026-05-18 4 M 0 9030 10.23 A 48200 I By Irrevocable Spousal Trust for Linda W. Cyr Common Stock 2026-05-18 4 S 0 1874 50.04 D 46326 I By Irrevocable Spousal Trust for Linda W. Cyr Common Stock 2026-05-15 4 M 0 7981 10.23 A 38809 I By Linda W. Cyr 2020 Irrevocable Trust for Descendants Common Stock 2026-05-15 4 S 0 1657 49.09 D 37152 I By Linda W. Cyr 2020 Irrevocable Trust for Descendants Common Stock 2026-05-18 4 M 0 7981 10.23 A 45133 I By Linda W. Cyr 2020 Irrevocable Trust for Descendants Common Stock 2026-05-18 4 S 0 1656 50.04 D 43477 I By Linda W. Cyr 2020 Irrevocable Trust for Descendants Options to purchase common stock 10.23 2026-05-15 4 M 0 62369 0 D 2026-09-06 Common Stock 62369 555393 D Options to purchase common stock 10.23 2026-05-18 4 M 0 62369 0 D 2026-09-06 Common Stock 62369 493024 D Options to purchase common stock 10.23 2026-05-15 4 M 0 4620 0 D 2026-09-06 Common Stock 4620 41140 I By Spouse Options to purchase common stock 10.23 2026-05-18 4 M 0 4620 0 D 2026-09-06 Common Stock 4620 36520 I By Spouse Options to purchase common stock 10.23 2026-05-15 4 M 0 9030 0 D 2026-09-06 Common Stock 9030 80410 I By Irrevocable Spousal Trust for Linda W. Cyr Options to purchase common stock 10.23 2026-05-18 4 M 0 9030 0 D 2026-09-06 Common Stock 9030 71380 I By Irrevocable Spousal Trust for Linda W. Cyr Options to purchase common stock 10.23 2026-05-15 4 M 0 7981 0 D 2026-09-06 Common Stock 7981 71057 I By Linda W. Cyr 2020 Irrevocable Trust for Descendants Options to purchase common stock 10.23 2026-05-18 4 M 0 7981 0 D 2026-09-06 Common Stock 7981 63076 I By Linda W. Cyr 2020 Irrevocable Trust for Descendants The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.81 to $48.74. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.81 to $49.80. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.83 to $49.89. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to $48.88. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.90 to $49.46. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.98 to $50.94. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.03 to $51.68. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. /s/ Andrew Lampert, as attorney-in-fact for the Reporting Person 2026-05-19